Accelerate Diagnostics Reports First Quarter 2023 Financial Results

Go back to Accelerate Diagnostics Reports First Quarter 2023 Financial Results

Accelerate Diagnostics (AXDX) Misses Q1 EPS by 2c

May 11, 2023 4:14 PM EDT

Accelerate Diagnostics (NASDAQ: AXDX) reported Q1 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $2.81 million versus the consensus estimate of $3.35 million.

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

... More